Have a personal or library account? Click to login
qPCR analysis of mesenchymal stem cell marker expression during the long-term culture of canine adipocyte derived stem cells Cover

qPCR analysis of mesenchymal stem cell marker expression during the long-term culture of canine adipocyte derived stem cells

Open Access
|Dec 2020

References

  1. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng., Tissue Eng; 2001;211–28; DOI:10.1089/107632701300062859.
  2. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human Adipose Tissue Is a Source of Multipotent Stem Cells. Mol Biol Cell. 2002;13:4279–95; DOI:10.1091/mbc.E02-02-0105.
  3. Zhu M, Zhou Z, Chen Y, Schreiber R, Ransom JT, Fraser JK, Hedrick MH, Pinkernell K, Kuo HC. Supplementation of fat grafts with adipose-derived regenerative cells improves long-term graft retention. Ann Plast Surg. 2010;64:222–8; DOI:10.1097/SAP.0b013e31819ae05c.
  4. Majumdar MK, Banks V, Peluso DP, Morris EA. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol. 2000;185:98–106; DOI:10.1002/1097-4652(200010)185:1<;98::AID-JCP9>3.0.CO;2-1.
  5. Planat-Bénard V, Menard C, André M, Puceat M, Perez A, Garcia-Verdugo JM, Pénicaud L, Casteilla L. Spontaneous Cardiomyocyte Differentiation from Adipose Tissue Stroma Cells. Circ Res. 2004;94:223–9; DOI:10.1161/01.RES.0000109792.43271.47.
  6. Halvorsen YDC, Franklin D, Bond AL, Hitt DC, Auchter C, Boskey AL, Paschalis EP, Wilkison WO, Gimble JM. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng. 2001;7:729–41; DOI:10.1089/107632701753337681.
  7. Li H, Zhu L, Chen H, Li T, Han Q, Wang S, Yao X, Feng H, Fan L, Gao S, Boyd R, Cao X, Zhu P, Li J, Keating A, Su X, Zhao RC. Generation of Functional Hepatocytes from Human Adipose-Derived MYC+ KLF4+ GMNN+ Stem Cells Analyzed by Single-Cell RNA-Seq Profiling. Stem Cells Transl Med. 2018;7:792–805; DOI:10.1002/sctm.17-0273.
  8. Abdanipour A, Tiraihi T, Delshad AR. Trans-differentiation of the adipose tissue-derived stem cells into neuron-like cells expressing neurotrophins by selegiline. Iran Biomed J. 2011;15:113–21; DOI:10.6091/IBJ.1011.2012.
  9. Keck M, Kober J, Riedl O, Kitzinger HB, Wolf S, Stulnig TM, Zeyda M, Gugerell A. Power assisted liposuction to obtain adipose-derived stem cells: Impact on viability and differentiation to adipocytes in comparison to manual aspiration. J Plast Reconstr Aesthetic Surg. 2014;67:e1; DOI:10.1016/j.bjps.2013.08.019.
  10. Tanikawa DYS, Aguena M, Bueno DF, Passos-Bueno MR, Alonso N. Fat grafts supplemented with adipose-derived stromal cells in the rehabilitation of patients with craniofacial microsomia. Plast Reconstr Surg. 2013;132:141–52; DOI:10.1097/PRS.0b013e3182910a82.
  11. Dompe C, Wasiatycz G, Mozdziak P, Jankowski M, Kempisty B. Current clinical applications of adipose-derived stem cells in humans and animals. Med J Cell Biol. 2019;7; DOI:10.2478/acb-2019-0014.
  12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–9; DOI:10.1016/0003-2697(87)90021-2.
  13. Palumbo P, Lombardi F, Siragusa G, Cifone M, Cinque B, Giuliani M. Methods of Isolation, Characterization and Expansion of Human Adipose-Derived Stem Cells (ASCs): An Overview. Int J Mol Sci. 2018;19:1897; DOI:10.3390/ijms19071897.
  14. Miana VV, Prieto González EA. Adipose tissue stem cells in regenerative medicine. Ecancermedicalscience. 2018;12; DOI:10.3332/ecancer.2018.822.
  15. Bacakova L, Zarubova J, Travnickova M, Musilkova J, Pajorova J, Slepicka P, Kasalkova NS, Svorcik V, Kolska Z, Motarjemi H, Molitor M. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells – a review. Biotechnol Adv. 2018;36:1111–26; DOI:10.1016/J.BIOTECHADV.2018.03.011.
  16. Dompe C, Kranc W, Jopek K, Kowalska K, Ciesiółka S, Chermuła B, Bryja A, Jankowski M, Perek J, Józkowiak M, Moncrieff L, Hutchings G, Janowicz K, Pawelczyk L, Bruska M, Petitte J, Mozdziak P, Kulus M, Piotrowska-Kempisty H, Spaczyński R, Nowicki M, Kempisty B. Muscle Cell Morphogenesis, Structure, Development and Differentiation Processes Are Significantly Regulated during Human Ovarian Granulosa Cells In Vitro Cultivation. J Clin Med. 2020;9:2006; DOI:10.3390/jcm9062006.
  17. Jankowski M, Dompe C, Sibiak R, Wąsiatycz G, Mozdziak P, Jaśkowski JM, Antosik P, Kempisty B, Dyszkiewicz-Konwińska M. In Vitro Cultures of Adipose-Derived Stem Cells: An Overview of Methods, Molecular Analyses, and Clinical Applications. Cells. 2020;9:1783; DOI:10.3390/cells9081783.
  18. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7; DOI:10.1080/14653240600855905.
  19. Dallas NA, Samuel S, Xia L, Fan F, Gray MJ, Lim SJ, Ellis LM. Endoglin (CD105): A marker of tumor vasculature and potential target for therapy. Clin Cancer Res. 2008;14:1931–7; DOI:10.1158/1078-0432.CCR-07-4478.
  20. Ollauri-Ibáñez C, Núñez-Gómez E, Egido-Turrión C, Silva-Sousa L, Díaz-Rodríguez E, Rodríguez-Barbero A, López-Novoa JM, Pericacho M. Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis. Angiogenesis. 2020;23:231–47; DOI:10.1007/s10456-019-09703-y.
  21. Cleary MA, Narcisi R, Focke K, van der Linden R, Brama PAJ, van Osch GJVM. Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potential. Osteoarthr Cartil. 2016;24:868–72; DOI:10.1016/j.joca.2015.11.018.
  22. Antonioli L, Pacher P, Vizi ES, Haskó G. CD39 and CD73 in immunity and inflammation. Trends Mol Med. 2013;19:355–67; DOI:10.1016/j.molmed.2013.03.005.
  23. Beavis PA, Stagg J, Darcy PK, Smyth MJ. CD73: A potent suppressor of antitumor immune responses. Trends Immunol. 2012;33:231–7; DOI:10.1016/j.it.2012.02.009.
  24. De Leve S, Wirsdörfer F, Jendrossek V. Targeting the immunomodulatory CD73/adenosine system to improve the therapeutic gain of radiotherapy. Front Immunol. 2019;10:698; DOI:10.3389/fimmu.2019.00698.
  25. Sauzay C, Voutetakis K, Chatziioannou AA, Chevet E, Avril T. CD90/Thy-1, a cancer-associated cell surface signaling molecule. Front Cell Dev Biol. 2019;7:66; DOI:10.3389/fcell.2019.00066.
  26. Kisselbach L, Merges M, Bossie A, Boyd A. CD90 expression on human primary cells and elimination of contaminating fibroblasts from cell cultures. Cytotechnology. 2009;59:31–44; DOI:10.1007/s10616-009-9190-3.
  27. Moraes DA, Sibov TT, Pavon LF, Alvim PQ, Bonadio RS, Da Silva JR, Pic-Taylor A, Toledo OA, Marti LC, Azevedo RB, Oliveira DM. A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells. Stem Cell Res Ther. 2016;7:97; DOI:10.1186/s13287-016-0359-3.
  28. AbuSamra DB, Aleisa FA, Al-Amoodi AS, Ahmed HMJ, Chin CJ, Abuelela AF, Bergam P, Sougrat R, Merzaban JS. Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44. Blood Adv. 2017;1:2799–816; DOI:10.1182/bloodadvances.2017004317.
  29. Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: Evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014;32:1380–9; DOI:10.1002/stem.1661.
  30. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (80). 1990;249:1431–3; DOI:10.1126/science.1698311.
  31. Lobba ARM, Forni MF, Carreira ACO, Sogayar MC. Differential expression of CD90 and CD14 stem cell markers in malignant breast cancer cell lines. Cytom Part A. 2012;81A:1084–91; DOI:10.1002/cyto.a.22220.
  32. Behm C, Blufstein A, Gahn J, Noroozkhan N, Moritz A, Rausch-Fan X, Andrukhov O. Soluble CD14 enhances the response of periodontal ligament stem cells to toll-like receptor 2 agonists. Mediators Inflamm. 2019;2019; DOI:10.1155/2019/8127301.
Language: English
Page range: 139 - 145
Submitted on: Oct 12, 2020
|
Accepted on: Nov 15, 2020
|
Published on: Dec 31, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Rut Bryl, Claudia Dompe, Maurycy Jankowski, Katarzyna Stefańska, Afsaneh Golkar Narenji, Jakub Kulus, Magdalena Kulus, Maria Wieczorkiewicz, Grzegorz Wąsiatycz, Jędrzej M. Jaśkowski, Mariusz Kaczmarek, James N. Petitte, Paul Mozdziak, Paweł Antosik, Dorota Bukowska, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.